Search

Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib.

… Thursday, March 1, 2012 Summary Research led by investigators at Memorial Sloan Kettering has identified a previously unknown mechanism of resistance to the newly approved melanoma drug vemurafenib. Memorial Sloan Kettering researchers have uncovered a previously unknown mechanism by which tumors can

Learn about Verdun Perry’s devotion to fund rare cancer research at MSK.

… Thursday, April 1, 2021 When Verdun “Vern” Perry opened an email in 2007 from his friend Dave Linn inviting him to a Spinning fundraiser for rare cancer research, he immediately responded, “I’m in.” A few moments later, Vern wrote back, “By the way, what is Spinning?” Soon, Vern had a new purpose in

New findings provide details about the hidden organization of the cytoplasm, showing it makes a big difference where in that cellular broth that messenger RNA (mRNA) get translated into proteins. The findings hold promise for increasing or altering the production of proteins in mRNA vaccines and therapies.

… Thursday, December 21, 2023 Highlights Messenger RNA (mRNA) is translated into proteins in the cytoplasm of cells. But rather than being a uniform “soup,” the cytoplasm is divided into multiple distinct compartments or regions. Each region is largely responsible for translating functionally similar types

A new study in flies reveals a previously unknown type of cooperation at work in muscle cells.

… Monday, May 13, 2019 Mutlinucleated muscle cells from flies Individual muscle cells from a fruit fly, with their nuclei shown in blue Muscles in the wall of a fly A fly's abdomen is lined with a patchwork of muscles (purple). Each muscle is a single cell. Mutlinucleated muscle cells from flies Up close

Through converging lines of research in stem cell biology, tissue regeneration, and immunity, Sloan Kettering Institute scientists are learning what makes metastatic cancer cells tick.

… Wednesday, February 27, 2019 Karuna Ganesh Medical oncologist Karuna Ganesh is studying ways to combat metastatic cancer and understand why and how it spreads. Photo: Michael Prince Karuna Ganesh and Joan Massagué Dr. Ganesh in the lab with Sloan Kettering Institute Director Joan Massagué. Photo: Karsten

MSK nurses receive prestigious Magnet® designation for the second time during an especially challenging year.

… Thursday, April 1, 2021 What the nurse appraiser saw at Memorial Sloan Kettering was so extraordinary, she couldn’t speak. She and two colleagues from Magnet® — a national program that rates top nursing programs around the country — had just left a three-day virtual site visit at MSK. Now, she was on

COVID-19 is continuing to make headlines around the world this year. Yet cancer will kill a larger number of people globally – 10 million every year. Patients with cancer are more vulnerable to contracting COVID-19, and have more than double the death rate from COVID-19 compared to patients without cancer.

… Tuesday, August 17, 2021 COVID-19 is continuing to make headlines around the world this year. Yet cancer will kill a larger number of people globally – 10 million every year.  Patients with cancer are more vulnerable to contracting COVID-19, and have more than double the death rate from COVID-19 compared

Neuropathologist and scientist Jason T. Huse has been selected by the Sontag Foundation as one of three Distinguished Scientist Award recipients for 2012.

… Friday, December 7, 2012 Neuropathologist and scientist Jason T. Huse has been selected by the Sontag Foundation as one of three Distinguished Scientist Award recipients for 2012. The annual award is given to researchers of outstanding promise who are early in their careers, with the goal of accelerating

Neuro-oncologist and renowned physician-scientist Ingo Mellinghoff will lead MSK’s distinguished Department of Neurology after previously serving as Acting Co-Chair.

… Wednesday, October 28, 2020 Neuro-oncologist Ingo K. Mellinghoff, MD , has been appointed Memorial Sloan Kettering’s (MSK) new Chair of the Department of Neurology.          Dr. Mellinghoff currently holds the Evnin Family Chair in Neuro-Oncology and runs a research lab in the Human Oncology and Pathogenesis

Memorial Sloan Kettering Cancer Center chemist Samuel J. Danishefsky will be honored with three major awards this spring. Dr. Danishefsky is the incumbent of a Eugene W. Kettering Chair and a member of the Molecular Pharmacology and Chemistry Program in the Sloan Kettering Institute.

… Saturday, April 1, 2006 Summary Memorial Sloan Kettering Cancer Center chemist Samuel J. Danishefsky will be honored with three major awards this spring. Dr. Danishefsky is the incumbent of a Eugene W. Kettering Chair and a member of the Molecular Pharmacology and Chemistry Program in the Sloan Kettering